RAP (ASX) Ann: ResApp Grants Option to Consumer Health Division of Sanofi

Originally posted by silverfox3731 ↑

Feeling Perplexed.
Maybe Great to be involved with a giant like Sanofi, it depends on what, where, how in terms of exclusivity though. Ping An etc sidelined partly or wholly?.
They always indicated direct to consumer would be later. Now its flagged as possibly next year in some shape or form whatever that may be.

We can earn huge revenues via Sanofi’s global footprint but is that at the cost of less telehealth market involvement.?

Is this mainly attractive to management as Sanofi pay US20+ million as part of the contract or a justifiable sensible lucrative deal in its own right that wont draw raised eyebrows and frowns.?

What will they jointly develop?. Nothing but some smart envelope around our core technology or is it integrated with other AI technologies to give more power and accuracy in diagnosis?

Will the outcomes be something that can only be used by Sanofi customers or The RAP/Sanofi product is available to everyone including telehealth companies.?.
Is it truly a bait to get Apple and others to show their hands?.

Will potential telehealth and hospital customers hold off purchasing our product in the light of this announcement?.
Will this make our efforts in developing those ruggedised devices redundant?.

Great posts in here as the HC brains trust starts digesting it today and exploring these kinds of issues.Thanks for the insights so far.
Perplexed Fox

Expand

I suppose there's only so much can be divulged as being fact when the collaboration has just begun, but we can speculate.

I had a run through @Phantom1 's content tonight and here's a few observations.

Firstly, I really appreciate the upfront and ongoing disclosure that he/she has an association with some of the RAP research; what capacity I don't know, but good to know.

Secondly, and I'm sorry to imply a link here if there isn't one, but contributions tend to be at times when we're looking for clarity. Like today.

Looking back, Phantom posted about the ERS International Conference in Spain (Sept/Oct '19) on September 5. Our participation in Creaosphere ws announced October 4. On October 23, Phantom posted about a paper out of WA and our tech's capacity to replicate (?) the Pulmonary Score results in asthma. This was also day one of Creaosphere.

Today an mou of sorts with Sanofi, with their integrated health platform (ongoing monitoring).

Joining the dots to me implies perhaps an integrated virtual asthma monitoring and treatment solution.

It's only an opinion and I'm happy to be corrected if I'm wrong.

Would be cool though...